100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
0 % Toleranz bei der Produktqualität
Lagerstandorte
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Vorbehaltlich Verfügbarkeit
Dokumentation
Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.
Eslicarbazepine-D4
● Auf Lager
| Katalog-Nr.:: | DVE002134 |
|---|---|
| CAS-Nr.:: | N/A |
| Summenformel:: | C15H10D4N2O2 |
| Molare Masse:: | 258.31 g/mol |
Zusätzliche Informationen zu
Parent drug
EslicarbazepineIUPAC-Name
(10S)-10,11-Dihydro-10-hydroxy-5H-Dibenz[b,f]azepine-5-carboxamide-D4Pharmacopeial Synonyms
N/ASynonyme
N/ASMILES
O=C(N1C2=C([2H])C([2H])=C([2H])C([2H])=C2C[C@H](O)C3=CC=CC=C31)NInChI
InChI=1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)/t14-/m0/s1/i1D,3D,5D,7DBeschreibung
Eslicarbazepine-D4 impurity is a deuterium-substituted isotopologue arising as a minor byproduct in synthetic routes to eslicarbazepine derivatives. Characterized by a +4 Da mass shift, this impurity requires targeted analytical characterization to ensure accurate impurity profiling and quantitation. Typical identification methods include LC-MS/MS for mass confirmation, high resolution MS for isotopic pattern, and 1H and 2H NMR for positional deuterium verification. Control strategies focus on process optimization, purification, and setting appropriate specification limits in line with ICH guidelines. Understanding its thermal stability, solvent solubility and chromatographic behavior supports robust impurity control and reliable quality assessment.Angebot anfordern
„*“ zeigt erforderliche Felder an
Other products related to Eslicarbazepine impurities
Verunreinigungsstruktur
Name der Muttersubstanz
CAS-Nr.:
Name der Verunreinigung
Katalog-Nr.:
Eslicarbazepine
CAS No. 1431547-12-4
Cat No. VE0027686